CurrentEndo
Get Weekly

CurrentEndo coverage · page 3 of 5

Diabetes & Metabolism

Briefs 81–120 of 190 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes & Metabolism

All coverage, newest first

  1. Diabetes Metab

    Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States

    Cohort studyObesity

  2. Diabetes Metab

    Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes

    Cohort studyLipids & liver

  3. Diabetes Metab

    Semaglutide 2.4 mg in French people living with Class 3 obesity and comorbidities: Baseline characteristics and real-world safety data

    Cohort studyObesity

  4. Diabetes Metab

    Increased ferritin levels are associated with incident diabetes after kidney transplantation: A prospective cohort study

    Cohort studyT2D & other

  5. Diabetes Metab

    Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus

    Cohort studyT2D & other

  6. Diabetes Metab

    Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus

    Cohort studyT2D & other

  7. Diabetes Metab

    Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes

    Cohort studyT2D & other

  8. Diabetes Metab

    Continuous glucose monitoring‑derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes

    Cohort studyTechnology

  9. Diabetes Metab

    Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin

    Meta-analysisDiabetes in pregnancy

  10. Diabetes Metab

    Glycemia Risk Index (GRI) and international glucose targets before and 6 months after initiation of hybrid closed loop system in the CIRDIA, a French multisite out-of-hospital center

    Cohort studyTechnology

  11. Diabetes Metab

    Lp(a) concentration and polymorphic size are not associated with new onset diabetes in individuals with prediabetes

    Cohort studyT2D & other

  12. Diabetes Metab

    Physical frailty, genetic predisposition, and type 2 diabetes mellitus

    Cohort studyT2D & other

  13. Diabetes Metab

    Dynamics of diabetes prevalence, incidence and mortality in France: A nationwide study, 2013–2021

    Cohort studyT2D & other

  14. Diabetes Metab

    Association between Type 2 Diabetes onset age and risk of cardiovascular disease and mortality: Two cohort studies from United Kingdom and Hong Kong

    Cohort studyT2D & other

  15. Diabetes Metab

    Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis

    Cohort studyT2D & other

  16. Diabetes Metab

    Weight loss therapy and addiction: Increased risk after bariatric surgery but reduced risk with GLP-1 receptor agonists

    Research articleObesity

  17. Diabetes Metab

    Epidemiology of major amputation following diabetic foot ulcer: Insights from recent nationwide data in the french national health registry (SNDS)

    Cohort studyComplications

  18. Diabetes Metab

    New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: A nationwide population-based cohort study

    Cohort studyT2D & other

  19. Diabetes Metab

    Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study

    Cohort studyT2D & other

  20. Diabetes Metab

    Screening and care for preclinical stage 1–2 type 1 diabetes in first-degree relatives: French expert position statement

    Guideline or statementT1D

  21. Diabetes Metab

    Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease

    Cross-sectional studyLipids & liver

  22. Diabetes Metab

    Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021

    Cohort studyObesity

  23. Diabetes Metab

    Impact of pre- and post-exercise strategies on hypoglycemic risk for two modalities of aerobic exercise among adults and adolescents living with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized controlled trial

    Randomized controlled trialTechnology

  24. Diabetes Metab

    One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals

    Cross-sectional studyObesity

  25. Diabetes Metab

    Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France

    Cohort studyT2D & other

  26. Diabetes Metab

    Association between adipose deposition and mortality among adults without major cardiovascular risk factors

    Cohort study

  27. Diabetes Metab

    Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies

    Meta-analysisT2D & other

  28. Diabetes Metab

    Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability

    Meta-analysisTechnology

  29. Diabetes Metab

    Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC) cohort

    Cohort studyT2D & other

  30. Diabetes Metab

    Association of SGLT2 inhibitors with incident cancer

    Cohort studyT2D & other

  31. Diabetes Metab

    Periodontitis adversely affects lipoprotein subfractions – results from the cohort study SHIP-TREND: Periodontitis adversely affects lipoprotein subfractions

    Cohort studyLipids & liver

  32. Diabetes Metab

    Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance

    Cross-sectional studyT2D & other

  33. Diabetes Metab

    Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study

    Cohort studyT2D & other

  34. Diabetes Metab

    Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study

    Cohort studyT2D & other

  35. Diabetes Metab

    Low hemoglobin, even within the normal range, is associated with diabetic kidney disease

    Cohort studyComplications

  36. Diabetes Metab

    Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study

    Cohort studyT2D & other

  37. Diabetes Metab

    Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss

    Cohort studyObesity

  38. Diabetes Metab

    Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study

    Cohort studyT2D & other

  39. Diabetes Metab

    Insulin-based or non-insulin-based insulin resistance indicators and risk of long-term cardiovascular and all-cause mortality in the general population: A 25-year cohort study

    Cohort study

  40. Diabetes Metab

    Attainment of LDL-cholesterol target in high cardiovascular risk type 1 diabetic French people

    Cohort studyT1D

All 190 Briefs in ExploreShowing Briefs 81–120 of 190, newest first